Compare EXPO & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXPO | AMRX |
|---|---|---|
| Founded | 1967 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.7B |
| IPO Year | 1996 | 2018 |
| Metric | EXPO | AMRX |
|---|---|---|
| Price | $65.36 | $12.48 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $88.00 | $15.60 |
| AVG Volume (30 Days) | 412.9K | ★ 1.3M |
| Earning Date | 04-30-2026 | 05-01-2026 |
| Dividend Yield | ★ 1.87% | N/A |
| EPS Growth | N/A | ★ 157.89 |
| EPS | ★ 2.07 | 0.22 |
| Revenue | ★ $582,014,000.00 | N/A |
| Revenue This Year | $12.75 | $4.48 |
| Revenue Next Year | $8.50 | $7.13 |
| P/E Ratio | ★ $31.95 | $57.32 |
| Revenue Growth | ★ 4.21 | N/A |
| 52 Week Low | $63.25 | $7.02 |
| 52 Week High | $81.95 | $15.42 |
| Indicator | EXPO | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 41.10 | 45.67 |
| Support Level | $64.33 | $12.50 |
| Resistance Level | $73.62 | $12.85 |
| Average True Range (ATR) | 2.02 | 0.49 |
| MACD | 0.09 | 0.01 |
| Stochastic Oscillator | 24.95 | 28.01 |
Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.